Researchers have made a significant breakthrough in cancer drug discovery by identifying a new binding site on the eukaryotic initiation factor 4 ...

A new modified silicone rubber for cancer-on-chip applications improves cell adhesion and drug testing, paving the way for ...

Dr Porebski, who won the ‘Researcher of the Year’ award at the 2024 Cambridge Independent Science and Technology Awards, ...

A method developed by a research group at Tampere University seeks specific molecules that can target desired tissues through ...

Announcing a new publication for Acta Materia Medica journal. Monoamine oxidase (MAO) is a useful target in the treatment of neurodegenerative diseases and depressive disorders.

Rare diseases (RD) are more common than you might think. For every 20 people you know, one is likely affected by a rare ...

Nanozymes are synthetic materials that have enzyme-like catalytic properties, and they are broadly used for biomedical purposes, such as disease ...

Announcing a new publication for Acta Materia Medica journal. Monoamine oxidase (MAO) is a useful target in the treatment of neurodegenerative diseases and depressive disorders. Understanding the ...

Strategic Combination Aims to Accelerate Biomarker Identification, Enhance Drug Discovery, and Expand Precision Medicine Applications in Cancer ...

A research has developed a method to detect harmful heavy metals through a selective catalytic double metal single atom in ...

Accelero Biostructures, founded in 2015, specializes in high-throughput protein X-ray crystallography for structure-based drug discovery and structural biology. Its proprietary platforms enable rapid ...